Adage Capital Partners Gp, L.L.C. Ideaya Biosciences, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.6 Billion
- Q3 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 980,094 shares of IDYA stock, worth $25.5 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
980,094
Previous 2,065,094
52.54%
Holding current value
$25.5 Million
Previous $72.5 Million
57.18%
% of portfolio
0.06%
Previous 0.14%
Shares
15 transactions
Others Institutions Holding IDYA
# of Institutions
216Shares Held
80.8MCall Options Held
69KPut Options Held
20K-
Black Rock Inc. New York, NY6.81MShares$177 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA5.21MShares$136 Million0.38% of portfolio
-
Janus Henderson Group PLC London, X05.16MShares$134 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.8MShares$125 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.02MShares$105 Million0.01% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.25B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...